期刊文献+

稳心颗粒联合阿替洛尔治疗扩张型心肌病并心律失常临床观察 被引量:6

Curative effect observation of Wenxin Granule combined with Atenolol on dilated cardiomyopathy with arhythmia
下载PDF
导出
摘要 目的观察稳心颗粒联合阿替洛尔治疗扩张型心肌病并心律失常的临床疗效。方法将扩张型心肌病并心律失常患者168例随机分为两2组。治疗组84例,给予稳心颗粒和阿替洛尔口服;对照组84例,单纯给予阿替洛尔口服。2组治疗时间为4周,分别观察治疗前后临床症状和动态心电图变化。结果治疗组临床总有效率90.48%,心电图总有效率84.52%;对照组临床总有效率76.19%,心电图总有效率66.67%。2组临床总有效率、心电图总有效率比较差异有统计学意义(P<0.05)。结论稳心颗粒联用阿替洛尔治疗扩张型心肌病并心律失常的效果比单独使用阿替洛尔明显增高,临床症状改善明显。 Objective To observe the clinical effect of Wenxin Granule combined with Atenolol on dilated cardiomyopathy (DCM) with arhythmia. Methods 168 patients with DCM) and arhythmia were randomly divided into two groups. Patients in treatment group ( n = 84) were treated by combination Wenxin Granule and Atenolol. 84 cases in control group were treated with oral Atenolo Only. The course was four weeks in two groups. Dynamic electrocardiogram (DCG) and therapeutic effect were observed before and after treatment. Results The total effective rate in treatment group (90.48%) was higher than that in control group (76.19%, P 〈0.05). The DCG effective rate (84.52%) is higher than that in control group (66.67%, P 〈0.05). Conclusion Combination of Wenxin Granule and Atenolol has a marked improvement compared with oral Atenolol only on the treatment of DCM. Patients'clinical symptoms were improved effectively.
出处 《河北中医》 2009年第12期1861-1863,共3页 Hebei Journal of Traditional Chinese Medicine
关键词 心肌病 扩张型 心律失常 心性 颗粒剂(中药) 阿替洛尔 中西医结合疗法 Dilated cardiomyopathy Arhythmia Granule Atenolol Traditional Chinese Medicine and Western Medicine therapy
  • 相关文献

参考文献8

二级参考文献7

  • 1陈新主编.临床心律失常学[M].北京:人民卫生出版社,2000.1148.
  • 2[1]β-Blocker Heart Attack Study Group. The β-blocker heart attack trail[J]. JAMA, 1981, 246: 2073-4.
  • 3[2]Viskin S, Kitzis I, Lev E, et al. Treatment with beta-adrenergic blocking agents after myocardial infarction: from randomized trails to clinical practice[J]. J Am Coll Cardiol, 1995, 25: 1327-32.
  • 4[3]Szabo BM, Crijms HJ, Wiesfeld AC, et al. Predicfors of mortality in patients with sustained ventricular tachycardias or ventricular fibrillation and depressed left ventricular function, importance of β-blockade[J]. Am Heart J, 1995, 130: 281-6.
  • 5[4]Scheinman MM, Levine JH, Cannom DS, et al. Doseranging study of intravenous amiodarone in patients with life-threatenning ventricular tachyarrhythmias[J]. Circulation, 1995, 92(11): 3264-72.
  • 6[5]Levine JH, Massumi A, Scheinman MM, et al. Intravenous amiodarone for recurrent sustained hypoteusive ventricular tachyarrhythmias[J]. J Am Coll Cardiol, 1996, 27(1): 67-75.
  • 7诸骏仁,李志善,陶萍,游凯,戚文航,尹秋熙,黄德嘉,周达新.普罗帕酮、莫雷西嗪、美西律的疗效和安全性再评价[J].中华心血管病杂志,1998,26(3):167-174. 被引量:105

共引文献213

同被引文献36

引证文献6

二级引证文献11

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部